Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study

• Main Authors: Salvatore D'Angelo (Author), Fabrizio Cantini (Author), Roberta Ramonda (Author), Luca Cantarini (Author), Antonio Carletto (Author), Maria Sole Chimenti (Author), Andrea Delle Sedie (Author), Rosario Foti (Author), Roberto Gerli (Author), Claudia Lomater (Author), Ennio Lubrano (Author), Antonio Marchesoni (Author), Alen Zabotti (Author), Carlo Salvarani (Author), Rossana Scrivo (Author), Raffaele Scarpa (Author), Giuseppina Tramontano (Author), Carlotta Nannini (Author), Mariagrazia Lorenzin (Author), Marta Fabbroni (Author), Federica Martinis (Author), Roberto Perricone (Author), Linda Carli (Author), Elisa Visalli (Author), Guido Rovera (Author), Fabio Massimo Perrotta (Author), Luca Quartuccio (Author), Alessio Altobelli (Author), Luisa Costa (Author), Laura Niccoli (Author), Augusta Ortolan (Author), Francesco Caso (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Few studies have evaluated the effectiveness of adalimumab in the real-life setting in psoriatic arthritis (PsA).Objective: To evaluate the 2-year retention rate of adalimumab in PsA patients. Potential baseline parameters influencing persistence on treatment were also evaluated.Methods:...